1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: 030176, 03-C-0176, NCI-03-C-0176, NCI-5911, 5911, NCT00062153, NCT00060528
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0309014, THERION-TBC-PRO-002, NCT00078585
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000422430, U10CA021115, ECOG-E9802, E9802, NCT00108732
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E1809, E1809, E1809, NCT01145508
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-05-C-0017, NCI-6066, 6066, NCT00098449
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-05-C-0167, 7207, NCI-7207, NCT00124670
|